Dr. rer. nat. Bengt-Frederik Belgardt, Dipl. Biol.
Deputy Director
Institute for Vascular and Islet Cell Biology
Head
Research Group Beta Cell Defects
+49 211 3382-451
Selected Publications
- Carstensen-Kirberg M, Röhrig K, Niersmann C, Ouwens DM, Belgardt BF, Roden M, Herder C 2019. Sfrp5 increases glucose-stimulated insulin secretion in the rat pancreatic beta cell line INS-1E. PLOS ONE. 14. https://doi.org/10.1371/journal.pone.0213650
- Belgardt B-F, Jarasch A, Lammert E 2018. Exploring biological and social networks to better understand and treat diabetes mellitus: Comment on "Network science of biological systems at different scales: A review" by Gosak et al. Phys Life Rev. 24: 146-148. https://doi.org/10.1016/j.plrev.2017.12.004
- Belgardt B-F, Lammert E 2016. DYRK1A: A Promising Drug Target for Islet Transplant-Based Diabetes Therapies. Diabetes. 65: 1496-8. https://doi.org/10.2337/dbi16-0013
- Belgardt B-F, Ahmed K, Spranger M, Latreille M, Denzler R, Kondratiuk N, von Meyenn F, Villena FN, Herrmanns K, Bosco D, Kerr-Conte J, Pattou F, Rülicke T, Stoffel M 2015. The microRNA-200 family regulates pancreatic beta cell survival in type 2 diabetes. Nat Med. 21: 619-27. https://doi.org/10.1038/nm.3862